{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:00:46Z","timestamp":1784797246464,"version":"3.55.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"publisher","award":["Substance Use and Addiction Program"],"award-info":[{"award-number":["Substance Use and Addiction Program"]}],"id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["EV1-174804"],"award-info":[{"award-number":["EV1-174804"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28140-3","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:35:14Z","timestamp":1781516114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cSafer supply is the thing that changes everything\u201d: the role of prescribed safer supply in rebuilding trust following experiences of medical abandonment"],"prefix":"10.1186","volume":"26","author":[{"given":"Gillian","family":"Kolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernie","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Toombs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Ranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbet","family":"Rygnestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Urbanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"28140_CR1","unstructured":"Federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses. Ottawa: Public Health Agency of Canada. 2023. Opioid- and stimulant-related harms in Canada. Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/. Cited 2023 Jan 25."},{"key":"28140_CR2","doi-asserted-by":"publisher","unstructured":"Fajber K, Sereda A, Warren S, Morris C, Nash G, Pauly B, et al. Comprehensive substance use services within primary care settings: The Safer Opioid Supply program at London InterCommunity Health Centre. Can J Public Health. 2025 Mar;12. https:\/\/doi.org\/10.17269\/s41997-025-01006-8.","DOI":"10.17269\/s41997-025-01006-8"},{"key":"28140_CR3","doi-asserted-by":"publisher","first-page":"103742","DOI":"10.1016\/j.drugpo.2022.103742","volume":"106","author":"S Glegg","year":"2022","unstructured":"Glegg S, McCrae K, Kolla G, Touesnard N, Turnbull J, Brothers TD, et al. COVID just kind of opened a can of whoop-ass: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada. Int J Drug Policy. 2022;106:103742. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103742.","journal-title":"Int J Drug Policy"},{"key":"28140_CR4","doi-asserted-by":"publisher","first-page":"104157","DOI":"10.1016\/j.drugpo.2023.104157","volume":"120","author":"M Karamouzian","year":"2023","unstructured":"Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, et al. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis. Int J Drug Policy. 2023;120:104157. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104157.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"28140_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12954-024-01029-3","volume":"21","author":"G Kolla","year":"2024","unstructured":"Kolla G, Pauly B, Cameron F, Hobbs H, Ranger C, McCall J, et al. If it wasn\u2019t for them, I don\u2019t think I would be here: experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis. Harm Reduct J. 2024;21(1):111. https:\/\/doi.org\/10.1186\/s12954-024-01029-3.","journal-title":"Harm Reduct J"},{"issue":"7","key":"28140_CR6","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/dar.13745","volume":"42","author":"RA Schmidt","year":"2023","unstructured":"Schmidt RA, Kaminski N, Kryszajtys DT, Rudzinski K, Perri M, Guta A, et al. I don\u2019t chase drugs as much anymore, and I\u2019m not dead\u2019: Client reported outcomes associated with safer opioid supply programs in Ontario, Canada. Drug Alcohol Rev. 2023;42(7):1825\u201337. https:\/\/doi.org\/10.1111\/dar.13745.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"28140_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12954-025-01344-3","volume":"22","author":"C Strike","year":"2025","unstructured":"Strike C, Rudzinski K, Schmidt RA, Kolla G, Kryszajits D, Perri M, et al. A sea of need: provider accounts of strategies used to manage admission demands to safer opioid supply programs in Ontario. Harm Reduct J. 2025;22(1):194. https:\/\/doi.org\/10.1186\/s12954-025-01344-3.","journal-title":"Harm Reduct J"},{"issue":"36","key":"28140_CR8","doi-asserted-by":"publisher","first-page":"E1233","DOI":"10.1503\/cmaj.220892","volume":"194","author":"T Gomes","year":"2022","unstructured":"Gomes T, Kolla G, McCormack D, Sereda A, Kitchen S, Antoniou T. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario. CMAJ. 2022;194(36):E1233\u201342. https:\/\/doi.org\/10.1503\/cmaj.220892 . PubMed PMID: 36122919.","journal-title":"CMAJ"},{"key":"28140_CR9","doi-asserted-by":"publisher","unstructured":"Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B, et al. Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ. 2024;e076336. https:\/\/doi.org\/10.1136\/bmj-2023-076336.","DOI":"10.1136\/bmj-2023-076336"},{"issue":"5","key":"28140_CR10","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1016\/S2468-2667","volume":"10","author":"T Gomes","year":"2025","unstructured":"Gomes T, McCormack D, Kolla G, Young S, Bayoumi AM, Smoke A, et al. Comparing the effects of prescribed safer opioid supply and methadone in Ontario, Canada: a population-based matched cohort study. Lancet Public Health. 2025;10(5):e412\u201321. https:\/\/doi.org\/10.1016\/S2468-2667. (25)00070-2 PubMed PMID: 40280140.","journal-title":"Lancet Public Health"},{"key":"28140_CR11","unstructured":"Atkinson K, Parkdale Queen West Community Health Center Safer Opioid Supply.: 2023 Evaluation Report . 2023 Mar. Available from: https:\/\/pqwchc.org\/programs-services\/harm-reduction\/safer-opioidsupply-sos-program"},{"issue":"1","key":"28140_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12954-023-00817-7","volume":"20","author":"M Gagnon","year":"2023","unstructured":"Gagnon M, Rudzinski K, Guta A, Schmidt RA, Kryszajtys DT, Kolla G, et al. Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada. Harm Reduct J. 2023;20(1):81. https:\/\/doi.org\/10.1186\/s12954-023-00817-7.","journal-title":"Harm Reduct J"},{"issue":"1","key":"28140_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12954-023-00776-z","volume":"20","author":"M Haines","year":"2023","unstructured":"Haines M, O\u2019Byrne P. Safer opioid supply: qualitative program evaluation. Harm Reduct J. 2023;20(1):53. https:\/\/doi.org\/10.1186\/s12954-023-00776-z.","journal-title":"Harm Reduct J"},{"key":"28140_CR14","doi-asserted-by":"publisher","unstructured":"Kalicum J, Nyx E, Kennedy MC, Kerr T. The impact of an unsanctioned compassion club on non-fatal overdose. Int J Drug Policy. 2024;104330. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104330.","DOI":"10.1016\/j.drugpo.2024.104330"},{"key":"28140_CR15","unstructured":"Kolla G, Long C, Perri M, Bowra A, Penn R. Safer Opioid Supply Program: Preliminary Report . London: London Intercommunity Health Center; 2021 Nov. p. 44. Available from: https:\/\/lihc.on.ca\/wp-content\/uploads\/2022\/01\/2021-SOS-Evaluation-Full.pdf"},{"key":"28140_CR16","doi-asserted-by":"publisher","first-page":"105124","DOI":"10.1016\/j.drugpo.2025.105124","volume":"148","author":"G Kolla","year":"2026","unstructured":"Kolla G, Lewis JL, Guta A, Schaff A, Boyle M, King K, et al. Reduced risk of overdose among clients of a safer opioid supply program in Southwestern Ontario: A pre-post observational cohort study. Int J Drug Policy. 2026;148:105124. https:\/\/doi.org\/10.1016\/j.drugpo.2025.105124.","journal-title":"Int J Drug Policy"},{"key":"28140_CR17","unstructured":"Kolla G, Fajber K. Safer Opioid Supply Program: A Comparison of SOS Client Outcomes From 2022 and 2023 . Ontario, Canada: London Intercommunity Health Center; 2023. Available from: https:\/\/www.nss-aps.ca\/sites\/default\/files\/resources\/2023-LIHC-SOS-Evaluation.pdf"},{"key":"28140_CR18","doi-asserted-by":"publisher","first-page":"104339","DOI":"10.1016\/j.drugpo.2024.104339","volume":"125","author":"S Ledlie","year":"2024","unstructured":"Ledlie S, Garg R, Cheng C, Kolla G, Antoniou T, Bouck Z, et al. Prescribed safer opioid supply: A scoping review of the evidence. Int J Drug Policy. 2024;125:104339. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104339.","journal-title":"Int J Drug Policy"},{"issue":"S2","key":"28140_CR19","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.2105\/AJPH.2021.306692","volume":"112","author":"R McNeil","year":"2022","unstructured":"McNeil R, Fleming T, Mayer S, Barker A, Mansoor M, Betsos A, et al. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021. Am J Public Health. 2022;112(S2):S151\u20138. https:\/\/doi.org\/10.2105\/AJPH.2021.306692.","journal-title":"Am J Public Health"},{"key":"28140_CR20","doi-asserted-by":"publisher","unstructured":"Nafeh F, Mbichila T, Bouck Z, Scheim A, Mitra S, Bonn M, et al. A Preliminary Assessment of Short-Term Social and Substance Use-Related Outcomes Among Clients of Integrated Safer Opioid Supply Pilot Programs in Toronto, Canada. Int J Ment Health Addict. 2023 Dec;22. https:\/\/doi.org\/10.1007\/s11469-023-01219-3.","DOI":"10.1007\/s11469-023-01219-3"},{"key":"28140_CR21","unstructured":"Perri M, Fajber K, Guta A, Strike C, Kolla G. Outcomes from the Safer Supply Program in Kitchener-Waterloo: Report 1. . 2023 Aug. Available from: https:\/\/www.nss-aps.ca\/sites\/default\/files\/resources\/2023-KWSaferSupplyReport1.pdf"},{"key":"28140_CR22","doi-asserted-by":"publisher","first-page":"103601","DOI":"10.1016\/j.drugpo.2022.103601","volume":"102","author":"S Young","year":"2022","unstructured":"Young S, Kolla G, McCormack D, Campbell T, Leece P, Strike C, et al. Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada. Int J Drug Policy. 2022;102:103601. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103601.","journal-title":"Int J Drug Policy"},{"key":"28140_CR23","doi-asserted-by":"publisher","unstructured":"Haines M, O\u2019Byrne P. Context of Substance Use: Harm Reduction and Safer Supply. J Drug Issues. 2024;00220426241231499. https:\/\/doi.org\/10.1177\/00220426241231499.","DOI":"10.1177\/00220426241231499"},{"key":"28140_CR24","doi-asserted-by":"publisher","unstructured":"Michaud L, Guta A, Perri M, Schaff A, Boyle M, King K, et al. With this you\u2019re not chained down to something: contrasting experiences of opioid agonist treatment and safer supply program participation among people receiving prescribed safer supply. Harm Reduct J. 2026 Feb;6. https:\/\/doi.org\/10.1186\/s12954-026-01409-x.","DOI":"10.1186\/s12954-026-01409-x"},{"issue":"S1","key":"28140_CR25","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.2105\/AJPH.2021.306500","volume":"112","author":"A Sud","year":"2022","unstructured":"Sud A, Buchman DZ, Furlan AD, Selby P, Spithoff SM, Upshur REG. Chronic Pain and Opioid Prescribing: Three Ways for Navigating Complexity at the Clinical\u2013Population Health Interface. Am J Public Health. 2022;112(S1):S56\u201365. https:\/\/doi.org\/10.2105\/AJPH.2021.306500.","journal-title":"Am J Public Health"},{"issue":"2","key":"28140_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","volume":"108","author":"N Dasgupta","year":"2018","unstructured":"Dasgupta N, Beletsky L, Ciccarone D. Opioid Crisis: No Easy Fix to Its Social and Economic Determinants. Am J public health (1971). 2018;108(2):182\u20136. https:\/\/doi.org\/10.2105\/AJPH.2017.304187.","journal-title":"Am J public health (1971)"},{"issue":"12","key":"28140_CR27","doi-asserted-by":"publisher","first-page":"e1004123","DOI":"10.1371\/journal.pmed.1004123","volume":"19","author":"MC Kennedy","year":"2022","unstructured":"Kennedy MC, Crabtree A, Nolan S, Mok WY, Cui Z, Chong M, et al. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study. PLoS Med. 2022;19(12):e1004123. https:\/\/doi.org\/10.1371\/journal.pmed.1004123.","journal-title":"PLoS Med"},{"issue":"4","key":"28140_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.12927\/hcpol.2019.25857","volume":"14","author":"J Shaw","year":"2019","unstructured":"Shaw J, Murphy AL, Turner JP, Gardner DM, Silvius JL, Bouck Z, et al. Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults. Healthc Policy. 2019;14(4):39\u201351. https:\/\/doi.org\/10.12927\/hcpol.2019.25857 . PubMed PMID: 31322113; PubMed Central PMCID: PMC7008681.","journal-title":"Healthc Policy"},{"issue":"1","key":"28140_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13011-019-0220-7","volume":"14","author":"S Taha","year":"2019","unstructured":"Taha S, Maloney-Hall B, Buxton J. Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy. Subst Abuse Treat Prev Policy. 2019;14(1):32. https:\/\/doi.org\/10.1186\/s13011-019-0220-7.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"5","key":"28140_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","volume":"326","author":"A Agnoli","year":"2021","unstructured":"Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids. JAMA. 2021;326(5):411\u20139. https:\/\/doi.org\/10.1001\/jama.2021.11013.","journal-title":"JAMA"},{"key":"28140_CR31","doi-asserted-by":"publisher","first-page":"108248","DOI":"10.1016\/j.drugalcdep.2020.108248","volume":"217","author":"IA Binswanger","year":"2020","unstructured":"Binswanger IA, Glanz JM, Faul M, Shoup JA, Quintana LM, Lyden J, et al. The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study. Drug Alcohol Depend. 2020;217:108248. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108248.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"28140_CR32","doi-asserted-by":"publisher","first-page":"e2216726","DOI":"10.1001\/jamanetworkopen.2022.16726","volume":"5","author":"JJ Fenton","year":"2022","unstructured":"Fenton JJ, Magnan E, Tseregounis IE, Xing G, Agnoli AL, Tancredi DJ. Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering. JAMA Netw Open. 2022;5(6):e2216726. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.16726.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"28140_CR33","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s11606-019-05301-2","volume":"34","author":"JR James","year":"2019","unstructured":"James JR, Scott JM, Klein JW, Jackson S, McKinney C, Novack M, et al. Mortality After Discontinuation of Primary Care\u2013Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study. J GEN INTERN MED. 2019;34(12):2749\u201355. https:\/\/doi.org\/10.1007\/s11606-019-05301-2.","journal-title":"J GEN INTERN MED"},{"key":"28140_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2019.05","volume":"103","author":"TL Mark","year":"2019","unstructured":"Mark TL, Parish W. Opioid medication discontinuation and risk of adverse opioid-related health care events. J Subst Abuse Treat. 2019;103:58\u201363. https:\/\/doi.org\/10.1016\/j.jsat.2019.05. .001 PubMed PMID: 31079950.","journal-title":"J Subst Abuse Treat"},{"key":"28140_CR35","doi-asserted-by":"publisher","first-page":"m283","DOI":"10.1136\/bmj.m283","volume":"368","author":"EM Oliva","year":"2020","unstructured":"Oliva EM, Bowe T, Manhapra A, Kertesz S, Hah JM, Henderson P, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020;368:m283. https:\/\/doi.org\/10.1136\/bmj.m283 . PubMed PMID: 32131996.","journal-title":"BMJ"},{"key":"28140_CR36","doi-asserted-by":"publisher","first-page":"108664","DOI":"10.1016\/j.drugalcdep.2021.108664","volume":"222","author":"A Benintendi","year":"2021","unstructured":"Benintendi A, Kosakowski S, Lagisetty P, Larochelle M, Bohnert ASB, Bazzi AR. I felt like I had a scarlet letter: Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain. Drug Alcohol Depend. 2021;222:108664. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108664.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"28140_CR37","doi-asserted-by":"publisher","first-page":"104485","DOI":"10.1016\/j.jpain.2024.01.350","volume":"25","author":"BJH Yarborough","year":"2024","unstructured":"Yarborough BJH, Stumbo SP, Schneider JL, Ahmedani BK, Daida YG, Hooker SA, et al. Patient Perspectives on Mental Health and Pain Management Support Needed Versus Received During Opioid Deprescribing. J Pain. 2024;25(7):104485. https:\/\/doi.org\/10.1016\/j.jpain.2024.01.350.","journal-title":"J Pain"},{"key":"28140_CR38","doi-asserted-by":"publisher","unstructured":"Schmidt RA, Guta A, Rai N, Sereda A, O\u2019Reilly E, Hales J, et al. Safer Opioid Supply programs: Hydromorphone prescribing in Ontario as a harm reduction intervention to combat the drug poisoning crisis. Can J Public Health. 2024 Dec;10. https:\/\/doi.org\/10.17269\/s41997-024-00979-2.","DOI":"10.17269\/s41997-024-00979-2"},{"key":"28140_CR39","doi-asserted-by":"publisher","unstructured":"Kolla G, Fajber K, Sereda A, Morris C, Deacon P, Cipriano LE. Opioid medication doses among safer supply clients: Current safer supply doses and previous OAT experience. Drug Alcohol Depend Rep. 2025;100338. https:\/\/doi.org\/10.1016\/j.dadr.2025.100338.","DOI":"10.1016\/j.dadr.2025.100338"},{"issue":"9","key":"28140_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S2215-0366(20)30231-5","volume":"7","author":"P Bach","year":"2020","unstructured":"Bach P, Robinson S, Sutherland C, Brar R. Innovative strategies to support physical distancing among individuals with active addiction. Lancet Psychiatry. 2020;7(9):731\u20133. https:\/\/doi.org\/10.1016\/S2215-0366(20)30231-5.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"28140_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13011-024-00598-7","volume":"19","author":"J McCall","year":"2024","unstructured":"McCall J, Hobbs H, Ranger C, Cameron F, Stuart H, Nelken J, et al. Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation. Subst Abuse Treat Prev Policy. 2024;19(1):19. https:\/\/doi.org\/10.1186\/s13011-024-00598-7.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"28140_CR42","doi-asserted-by":"publisher","first-page":"103849","DOI":"10.1016\/j.drugpo.2022.103849","volume":"110","author":"B Pauly","year":"2022","unstructured":"Pauly B, McCall J, Cameron F, Stuart H, Hobbs H, Sullivan G, et al. A concept mapping study of service user design of safer supply as an alternative to the illicit drug market. Int J Drug Policy. 2022;110:103849. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103849.","journal-title":"Int J Drug Policy"},{"key":"28140_CR43","unstructured":"Ranger C, Hobbs H, Cameron F, Stuart H, McCall J, Sullivan G et al. Co\/Lab Practice Brief: Implementing the Victoria SAFER Initiative . Victoria, BC: Canadian Institute for Substance Use Research, University of Victoria. Available from: https:\/\/www.uvic.ca\/research\/centres\/cisur\/assets\/docs\/colab\/practice-brief-safer.pdf"},{"key":"28140_CR44","doi-asserted-by":"publisher","first-page":"113156","DOI":"10.1016\/j.drugalcdep.2026.113156","volume":"283","author":"K Fajber","year":"2026","unstructured":"Fajber K, Pauly B, Ranger C, Cameron F, Clayton E, Rygnestad L, et al. The Victoria SAFER initiative: A community-based prescribed safer supply program using fentanyl formulations in Victoria, BC. Drug Alcohol Depend. 2026;283:113156. https:\/\/doi.org\/10.1016\/j.drugalcdep.2026.113156.","journal-title":"Drug Alcohol Depend"},{"key":"28140_CR45","unstructured":"CATIE. CATIE - Canada\u2019s source for HIV and hepatitis C information . 2023 [cited 2023 Apr 15]. Victoria SAFER Initiative. Available from: https:\/\/www.catie.ca\/programming-connection\/victoria-safer-initiative"},{"issue":"2","key":"28140_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qualitative Res Psychol"},{"issue":"4","key":"28140_CR47","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","volume":"11","author":"V Braun","year":"2019","unstructured":"Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qualitative Res Sport Exerc Health. 2019;11(4):589\u201397. https:\/\/doi.org\/10.1080\/2159676X.2019.1628806.","journal-title":"Qualitative Res Sport Exerc Health"},{"issue":"2","key":"28140_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/2159676X.2019.1704846","volume":"13","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Res Sport Exerc Health. 2021;13(2):201\u201316. https:\/\/doi.org\/10.1080\/2159676X.2019.1704846.","journal-title":"Qualitative Res Sport Exerc Health"},{"key":"28140_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.drugpo.2019.01.015","volume":"66","author":"T Antoniou","year":"2019","unstructured":"Antoniou T, Ala-Leppilampi K, Shearer D, Parsons JA, Tadrous M, Gomes T. Like being put on an ice floe and shoved away: A qualitative study of the impacts of opioid-related policy changes on people who take opioids. Int J Drug Policy. 2019;66:15\u201322. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.015.","journal-title":"Int J Drug Policy"},{"key":"28140_CR50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.drugpo.2019.03.023","volume":"71","author":"L Dassieu","year":"2019","unstructured":"Dassieu L, Kabor\u00e9 JL, Choini\u00e8re M, Arruda N, Roy \u00c9. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis. Int J Drug Policy. 2019;71:150\u20136. https:\/\/doi.org\/10.1016\/j.drugpo.2019.03.023.","journal-title":"Int J Drug Policy"},{"key":"28140_CR51","doi-asserted-by":"publisher","first-page":"104173","DOI":"10.1016\/j.drugpo.2023.104173","volume":"120","author":"L Comer","year":"2023","unstructured":"Comer L. The social organization of opioid policies and their implications for people with chronic pain and clinicians: An institutional ethnography. Int J Drug Policy. 2023;120:104173. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104173.","journal-title":"Int J Drug Policy"},{"issue":"S5","key":"28140_CR52","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/jia2.70038","volume":"28","author":"A Guta","year":"2025","unstructured":"Guta A, Rudzinski K, Gagnon M, Schmidt RA, Kolla G, German D, et al. From an HCV and HIV point of view, it\u2019s been remarkable: A qualitative study about using prescribed safer supply to support people who use drugs along the HIV and HCV prevention and treatment cascades in Ontario, Canada. J Int AIDS Soc. 2025;28(S5):e70038. https:\/\/doi.org\/10.1002\/jia2.70038.","journal-title":"J Int AIDS Soc"},{"key":"28140_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"28140_CR54","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","volume":"108","author":"AL Pitt","year":"2018","unstructured":"Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. Am J Public Health. 2018;108(10):1394\u2013400. https:\/\/doi.org\/10.2105\/AJPH.2018.304590.","journal-title":"Am J Public Health"},{"issue":"1","key":"28140_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12927\/hcq.2011.22153","volume":"14","author":"T Gomes","year":"2011","unstructured":"Gomes T, Juurlink D, Moineddin R, Gozdyra P, Dhalla I, Paterson M, et al. Geographical Variation in Opioid Prescribing and Opioid-Related Mortality in Ontario. hcq. 2011;14(1):22\u20134. https:\/\/doi.org\/10.12927\/hcq.2011.22153.","journal-title":"hcq"},{"key":"28140_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13011-021-00396-5","volume":"16","author":"W Jones","year":"2021","unstructured":"Jones W, Kaoser R, Fischer B. Patterns, trends and determinants of medical opioid utilization in Canada 2005\u20132020: characterizing an era of intensive rise and fall. Subst Abuse Treat Prev Policy. 2021;16:65. https:\/\/doi.org\/10.1186\/s13011-021-00396-5 . PubMed PMID: 34521418; PubMed Central PMCID: PMC8438558.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"28140_CR57","doi-asserted-by":"publisher","unstructured":"Jones W, Lee MH (Angelica), Kaoser R, Fischer B, editors. Correlations between Changes in Medical Opioid Dispensing and Contributions of Fentanyl to Opioid-Related Overdose Fatalities: Exploratory Analyses from Canada. International Journal of Environmental Research and Public Health. 2021;18(14):14. https:\/\/doi.org\/10.3390\/ijerph18147507","DOI":"10.3390\/ijerph18147507"},{"key":"28140_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12927\/hcq.2022.26896","volume":"25","author":"T Gomes","year":"2022","unstructured":"Gomes T, Kitchen S, Campbell T, Murray R, Leece P, Observatory G. Responding to Ontario\u2019s Overdose Crisis in the Context of the COVID-19 Pandemic. Healthc Q. 2022;25:7\u201312. https:\/\/doi.org\/10.12927\/hcq.2022.26896.","journal-title":"Healthc Q"},{"issue":"1","key":"28140_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12954-019-0285-7","volume":"16","author":"S Chan Carusone","year":"2019","unstructured":"Chan Carusone S, Guta A, Robinson S, Tan DH, Cooper C, O\u2019Leary B, et al. Maybe if I stop the drugs, then maybe they\u2019d care?\u2014hospital care experiences of people who use drugs. Harm Reduct J. 2019;16(1):16. https:\/\/doi.org\/10.1186\/s12954-019-0285-7.","journal-title":"Harm Reduct J"},{"key":"28140_CR60","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.ajmo.2025.100106","volume":"14","author":"NJ Christian","year":"2025","unstructured":"Christian NJ, Baysinger A, Bottner R, Cowley C, Nekolaichuk R, Owen P, et al. Hospital-Based Stigma Practices Towards Individuals With Opioid Use Disorder: A Qualitative Study in Austin, Texas. Am J Med Open. 2025;14:100106. https:\/\/doi.org\/10.1016\/j.ajmo.2025.100106 . PubMed PMID: 41036173; PubMed Central PMCID: PMC12481101.","journal-title":"Am J Med Open"},{"key":"28140_CR61","doi-asserted-by":"publisher","first-page":"101587","DOI":"10.1016\/j.lanepe.2025.101587","volume":"63","author":"M Luderer","year":"2026","unstructured":"Luderer M, Stockreiter D, Binder A, M\u00fcller L, Burger F, St\u00fcben N, et al. Stigma from healthcare professionals and care-limiting behaviors in individuals with substance use disorders: a mixed-methods study. Lancet Reg Health Eur. 2026;63:101587. https:\/\/doi.org\/10.1016\/j.lanepe.2025.101587 . PubMed PMID: 41585028; PubMed Central PMCID: PMC12828365.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"28140_CR62","doi-asserted-by":"publisher","first-page":"e0229713","DOI":"10.1371\/journal.pone.0229713","volume":"15","author":"C Strike","year":"2020","unstructured":"Strike C, Robinson S, Guta A, Tan DH, O\u2019Leary B, Cooper C, et al. Illicit drug use while admitted to hospital: Patient and health care provider perspectives. PLoS ONE. 2020;15(3):e0229713. https:\/\/doi.org\/10.1371\/journal.pone.0229713.","journal-title":"PLoS ONE"},{"issue":"12","key":"28140_CR63","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1007\/s11606-024-09129-3","volume":"40","author":"R Weger","year":"2025","unstructured":"Weger R, Weinstock N, Jawa R, Wilson JD. We\u2019re Not Gonna Aid You in Shooting Up: Stigma\u2019s Relationship to Harm Reduction in People Who Inject Drugs. J Gen Intern Med. 2025;40(12):2870\u20138. https:\/\/doi.org\/10.1007\/s11606-024-09129-3 . PubMed PMID: 39448507; PubMed Central PMCID: PMC12463774.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"28140_CR64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.7326\/M21-3968","volume":"175","author":"RA Kleinman","year":"2022","unstructured":"Kleinman RA, Wakeman SE. Treating Opioid Withdrawal in the Hospital: A Role for Short-Acting Opioids. Ann Intern Med. 2022;175(2):283\u20134. https:\/\/doi.org\/10.7326\/M21-3968.","journal-title":"Ann Intern Med"},{"issue":"4","key":"28140_CR65","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","volume":"41","author":"R Simon","year":"2020","unstructured":"Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus. 2020;41(4):519\u201325. 2019.1671942 PubMed PMID: 31638862.","journal-title":"Subst Abus"},{"issue":"7","key":"28140_CR66","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/add.15862","volume":"117","author":"T Gomes","year":"2022","unstructured":"Gomes T, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, et al. Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study. Addiction. 2022;117(7):1972\u201381. https:\/\/doi.org\/10.1111\/add.15862.","journal-title":"Addiction"},{"key":"28140_CR67","doi-asserted-by":"publisher","unstructured":"Iacono A, Wang T, Tadrous M, Campbell T, Kolla G, Leece P, et al. Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: a population-based cohort study in Ontario, Canada. Drug Alcohol Depend. 2023;111032. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.111032.","DOI":"10.1016\/j.drugalcdep.2023.111032"},{"key":"28140_CR68","doi-asserted-by":"publisher","unstructured":"Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, et al. Buprenorphine\/Naloxone vs Methadone for the Treatment of Opioid Use Disorder. JAMA. 2024 Oct;17. https:\/\/doi.org\/10.1001\/jama.2024.16954.","DOI":"10.1001\/jama.2024.16954"},{"issue":"1","key":"28140_CR69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","volume":"18","author":"D Frank","year":"2021","unstructured":"Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. It\u2019s like \u2018liquid handcuffs: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients\u2019 lives. Harm Reduct J. 2021;18(1):88. https:\/\/doi.org\/10.1186\/s12954-021-00535-y.","journal-title":"Harm Reduct J"},{"issue":"S2","key":"28140_CR70","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.2105\/AJPH.2021.306665","volume":"112","author":"C Simon","year":"2022","unstructured":"Simon C, Vincent L, Coulter A, Salazar Z, Voyles N, Roberts L, et al. The Methadone Manifesto: Treatment Experiences and Policy Recommendations From Methadone Patient Activists. Am J Public Health. 2022;112(S2):S117\u201322. https:\/\/doi.org\/10.2105\/AJPH.2021.306665.","journal-title":"Am J Public Health"},{"key":"28140_CR71","doi-asserted-by":"publisher","unstructured":"Gomes T, McCormack D, Kolla G, Young S, Bayoumi AM, Smoke A, et al. Comparing the effects of prescribed safer opioid supply and methadone in Ontario, Canada: a population-based matched cohort study. Lancet Public Health. 2025;0(0). https:\/\/doi.org\/10.1016\/S2468-2667. (25)00070-2 PubMed PMID: 40280140.","DOI":"10.1016\/S2468-2667"},{"issue":"5","key":"28140_CR72","doi-asserted-by":"publisher","first-page":"e2411389","DOI":"10.1001\/jamanetworkopen.2024.11389","volume":"7","author":"JE Min","year":"2024","unstructured":"Min JE, Guerra-Alejos BC, Yan R, Palis H, Barker B, Urbanoski K, et al. Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt. JAMA Netw Open. 2024;7(5):e2411389. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.11389.","journal-title":"JAMA Netw Open"},{"key":"28140_CR73","doi-asserted-by":"publisher","unstructured":"Socias ME, Choi JC, Fairbairn N, Johnson C, Wilson D, Debeck K, et al. Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis. Int J Drug Policy. 2023;104075. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104075.","DOI":"10.1016\/j.drugpo.2023.104075"},{"key":"28140_CR74","doi-asserted-by":"publisher","DOI":"10.1136\/jme-2021-108087","author":"K Duthie","year":"2022","unstructured":"Duthie K, Mathison E, Eyford H, Ghosh SM. Prescribing safe supply: ethical considerations for clinicians. J Med Ethics. 2022. https:\/\/doi.org\/10.1136\/jme-2021-108087. medethics-2021-108087.","journal-title":"J Med Ethics"},{"issue":"0","key":"28140_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09687637.2023.2283383","volume":"0","author":"C Macevicius","year":"2023","unstructured":"Macevicius C, Gudi\u00f1o P\u00e9rez D, Norton A, Kolla G, Beck-McGreevy P, Selfridge M, et al. Just have this come from their prescription pad: the medicalization of safer supply from the perspectives of health planners in BC, Canada. Drugs: Educ Prev Policy. 2023;0(0):1\u201311. https:\/\/doi.org\/10.1080\/09687637.2023.2283383.","journal-title":"Drugs: Educ Prev Policy"},{"key":"28140_CR76","doi-asserted-by":"publisher","first-page":"104423","DOI":"10.1016\/j.drugpo.2024.104423","volume":"127","author":"L Michaud","year":"2024","unstructured":"Michaud L, Kolla G, Rudzinski K, Guta A. Mapping a moral panic: News media narratives and medical expertise in public debates on safer supply, diversion, and youth drug use in Canada. Int J Drug Policy. 2024;127:104423. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104423.","journal-title":"Int J Drug Policy"},{"key":"28140_CR77","unstructured":"Ministry of Health. Prescribed alternatives - Province of British Columbia . Province of British Columbia; 2025 [cited 2026 Feb 19]. Available from: https:\/\/www2.gov.bc.ca\/gov\/content\/health\/practitioner-professional-resources\/pharmacare\/pharmacare-substance-use-disorder-hub\/pa"},{"key":"28140_CR78","doi-asserted-by":"publisher","first-page":"104731","DOI":"10.1016\/j.drugpo.2025.104731","volume":"137","author":"M Haines","year":"2025","unstructured":"Haines M, Hill E, O\u2019Byrne P. Safer supply programs: Discussions on medication diversion, sharing, and selling. Int J Drug Policy. 2025;137:104731. https:\/\/doi.org\/10.1016\/j.drugpo.2025.104731.","journal-title":"Int J Drug Policy"},{"key":"28140_CR79","doi-asserted-by":"publisher","first-page":"104665","DOI":"10.1016\/j.drugpo.2024.104665","volume":"135","author":"L Martignetti","year":"2025","unstructured":"Martignetti L, Knight R, Nafeh F, Atkinson K, Laurence G, Johnson CH, et al. Motivations for and perspectives of medication diversion among clients of a safer opioid supply program in Toronto, Canada. Int J Drug Policy. 2025;135:104665. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104665.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"28140_CR80","doi-asserted-by":"publisher","first-page":"e2451988","DOI":"10.1001\/jamanetworkopen.2024.51988","volume":"7","author":"M Olding","year":"2024","unstructured":"Olding M, Rudzinski K, Schmidt R, Kolla G, German D, Sereda A, et al. Perspectives on Diversion of Medications From Safer Opioid Supply Programs. JAMA Netw Open. 2024;7(12):e2451988. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.51988.","journal-title":"JAMA Netw Open"},{"key":"28140_CR81","doi-asserted-by":"publisher","unstructured":"Bird K, Genuis Q, Ickowicz S. Clinicians\u2019 Perspectives and an Ethical Analysis of Safer Supply Opioid Prescribing. Bioethical Inq. 2024 Oct;28. https:\/\/doi.org\/10.1007\/s11673-024-10387-3.","DOI":"10.1007\/s11673-024-10387-3"},{"key":"28140_CR82","doi-asserted-by":"publisher","first-page":"104721","DOI":"10.1016\/j.drugpo.2025.104721","volume":"137","author":"TN Rieder","year":"2025","unstructured":"Rieder TN. Ethical justifications for safe supply interventions. Int J Drug Policy. 2025;137:104721. https:\/\/doi.org\/10.1016\/j.drugpo.2025.104721.","journal-title":"Int J Drug Policy"},{"key":"28140_CR83","unstructured":"BC Centre on Substance Use. Clinical Bulletin: Updated Prescribed Alternatives Policy-Implications for Clinical Practice . 2025 Jan 12. Available from: https:\/\/www.bccsu.ca\/wp-content\/uploads\/2025\/12\/Clinical-Bulletin-Prescribed-Alternatives-Policy-Implications-for-Clinical-Practice_Website-Version-for-1Dec2025.pdf"},{"key":"28140_CR84","unstructured":"BC Ministry of Health. Access to Prescribed Alternatives in British Columbia: Policy Direction. 2025. Available from: https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/managing-your-health\/mental-health-substance-use\/information-sharing\/prescribed_alternatives_policy.pdf"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28140-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28140-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28140-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:02:20Z","timestamp":1784793740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28140-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28140"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28140-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors obtained all required ethical approvals for the work reported in this paper and our study adhered to the Declaration of Helsinki prinicples. The University of Victoria Research Ethics Board approved this study. Informed consent was obtained from all participants prior to their participation in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2215"}}